Xiaozhi Lv

690 total citations
38 papers, 515 citations indexed

About

Xiaozhi Lv is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xiaozhi Lv has authored 38 papers receiving a total of 515 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 17 papers in Cancer Research and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xiaozhi Lv's work include Cancer-related molecular mechanisms research (12 papers), RNA modifications and cancer (12 papers) and Circular RNAs in diseases (9 papers). Xiaozhi Lv is often cited by papers focused on Cancer-related molecular mechanisms research (12 papers), RNA modifications and cancer (12 papers) and Circular RNAs in diseases (9 papers). Xiaozhi Lv collaborates with scholars based in China and Sudan. Xiaozhi Lv's co-authors include Guangzhao Huang, Qingqing Wu, Weisen Zeng, Chen Zou, Yilong Ai, Siyuan Wu, Zhe Tang, Xia Li, Fei Li and Jiaxin Huang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biochemical and Biophysical Research Communications and Life Sciences.

In The Last Decade

Xiaozhi Lv

35 papers receiving 509 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaozhi Lv China 12 387 276 97 66 41 38 515
Fengtao Su China 10 307 0.8× 138 0.5× 148 1.5× 49 0.7× 24 0.6× 20 447
Ye‐Lin Liang China 12 410 1.1× 304 1.1× 104 1.1× 54 0.8× 16 0.4× 21 541
Tianliang Xia China 12 241 0.6× 125 0.5× 119 1.2× 81 1.2× 22 0.5× 21 366
Yi‐Kan Cheng China 9 243 0.6× 182 0.7× 126 1.3× 29 0.4× 46 1.1× 18 398
Xi-Rong Tan China 9 240 0.6× 104 0.4× 88 0.9× 41 0.6× 20 0.5× 17 339
Gaofeng Li China 9 224 0.6× 151 0.5× 64 0.7× 57 0.9× 20 0.5× 27 326
Monique C. de Jong Netherlands 11 191 0.5× 175 0.6× 159 1.6× 105 1.6× 50 1.2× 13 443
Kazuki Heishima Japan 13 287 0.7× 222 0.8× 65 0.7× 116 1.8× 31 0.8× 36 453
Changhao Zhu China 10 392 1.0× 319 1.2× 117 1.2× 65 1.0× 31 0.8× 29 527

Countries citing papers authored by Xiaozhi Lv

Since Specialization
Citations

This map shows the geographic impact of Xiaozhi Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaozhi Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaozhi Lv more than expected).

Fields of papers citing papers by Xiaozhi Lv

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaozhi Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaozhi Lv. The network helps show where Xiaozhi Lv may publish in the future.

Co-authorship network of co-authors of Xiaozhi Lv

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaozhi Lv. A scholar is included among the top collaborators of Xiaozhi Lv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaozhi Lv. Xiaozhi Lv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Jingshu, Hui Yang, Xiaolong Cao, et al.. (2025). A multicenter, randomized, open label, two formulation, crossover bioequivalence trial of doxorubicin hydrochloride liposomal injection in Chinese patients with metastatic breast cancer. Journal of Cancer Research and Clinical Oncology. 151(1). 41–41.
2.
Lv, Xiaozhi, et al.. (2024). A modified supraclavicular artery island flap for reconstruction of oral and maxillofacial defects. Oral Surgery Oral Medicine Oral Pathology and Oral Radiology. 138(4). 469–474.
3.
4.
Cheng, Di, Jingshu Wang, Xiaozhi Lv, et al.. (2024). Phase I Trial of Upamostat Combined With Gemcitabine in Locally Unresectable or Metastatic Pancreatic Cancer: Safety and Preliminary Efficacy Assessment. Cancer Medicine. 14(1). e70550–e70550. 2 indexed citations
5.
Wu, Siyuan, Xiaozhi Lv, Shiwei Liu, et al.. (2023). The Potential Mechanism of Curcumin in Treating Oral Squamous Cell Carcinoma Based on Integrated Bioinformatic Analysis. International Journal of Genomics. 2023. 1–13.
6.
Zou, Chen, Xiaozhi Lv, Siyuan Wu, et al.. (2023). SP2‐induced circPUM1 modulates chemoresistance and nature killer cell toxicity in oral squamous cell carcinoma. Journal of Cellular and Molecular Medicine. 28(5). e17888–e17888. 3 indexed citations
7.
Wu, Siyuan, Xiaozhi Lv, Wuya Chen, et al.. (2023). Circ‐ILF2 in oral squamous cell carcinoma promotes cisplatin resistance and induces M2 polarization of macrophages. Journal of Cellular and Molecular Medicine. 27(24). 4133–4144. 10 indexed citations
8.
Huang, Guangzhao, et al.. (2022). Metabolism-Related Bioinformatics Analysis Reveals That HPRT1 Facilitates the Progression of Oral Squamous Cell Carcinoma In Vitro. Journal of Oncology. 2022. 1–16. 3 indexed citations
9.
Huang, Jiaxin, et al.. (2021). Evaluating the prognosis of oral squamous cell carcinoma patients via L3 skeletal muscle index. Oral Diseases. 29(3). 923–932. 7 indexed citations
10.
Ai, Yilong, Shiwei Liu, Siyuan Wu, et al.. (2021). METTL3 Intensifies the Progress of Oral Squamous Cell Carcinoma via Modulating the m6A Amount of PRMT5 and PD-L1. Journal of Immunology Research. 2021. 1–15. 45 indexed citations
11.
Huang, Guangzhao, Qingqing Wu, Fei Li, et al.. (2021). Bioinformatics Analyses Indicate That Cathepsin G (CTSG) is a Potential Immune-Related Biomarker in Oral Squamous Cell Carcinoma (OSCC). OncoTargets and Therapy. Volume 14. 1275–1289. 23 indexed citations
12.
Huang, Guangzhao, et al.. (2020). NF-κB-mediated lncRNA AC007271.3 promotes carcinogenesis of oral squamous cell carcinoma by regulating miR-125b-2-3p/Slug. Cell Death and Disease. 11(12). 1055–1055. 21 indexed citations
13.
Lv, Xiaozhi, et al.. (2020). Regulatory T-cell expansion in oral and maxillofacial Langerhans cell histiocytosis. Oral Surgery Oral Medicine Oral Pathology and Oral Radiology. 130(5). 547–556. 1 indexed citations
14.
15.
Huang, Guangzhao, et al.. (2019). Identification of Candidate Biomarkers and Analysis of Prognostic Values in Oral Squamous Cell Carcinoma. Frontiers in Oncology. 9. 1054–1054. 56 indexed citations
16.
17.
Huang, Jiaxin, et al.. (2018). SCCA, TSGF, and the Long Non-Coding RNA AC007271.3 are Effective Biomarkers for Diagnosing Oral Squamous Cell Carcinoma. Cellular Physiology and Biochemistry. 47(1). 26–38. 34 indexed citations
18.
Gao, Wen, Wei Sun, Rina Su, et al.. (2016). Sheep YAP1 temporal and spatial expression trend and its relation with MyHCs expression. Genetics and Molecular Research. 15(2). 4 indexed citations
19.
20.
Lv, Xiaozhi, Rong Ni, Wei Sun, et al.. (2016). Candidate genes for the development of hair follicles in Hu sheep. Genetics and Molecular Research. 15(3). 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fengtao Su Breakdown of academic impact, for papers by Ye‐Lin Liang Breakdown of academic impact, for papers by Tianliang Xia Breakdown of academic impact, for papers by Yi‐Kan Cheng Breakdown of academic impact, for papers by Xi-Rong Tan Breakdown of academic impact, for papers by Gaofeng Li Breakdown of academic impact, for papers by Monique C. de Jong Breakdown of academic impact, for papers by Kazuki Heishima Breakdown of academic impact, for papers by Changhao Zhu
Rankless by CCL
2026